OUR THIRD QUARTER

QUARTERLY STATEMENT THIRD QUARTER

DECEMBER 2019 - AUGUST 2020

2

GROUP KEY FIGURES

Financial Year ended November 30

Q3 2020

Change

Q1-Q3 2020

Change

Q3 2019

in %7)

Q1-Q3 2019

in %7)

Results of Operations

during Reporting Period in EUR m

Revenues

349.2

358.6

-2.6

1,016.0

1,023.6

-0.7

Adjusted EBITDA1)

75.0

72.2

4.1

210.2

318.5

-34.0

in % of revenues

21.5

20.1

-

20.7

31.1

-

Adjusted EBITA1)

48.7

48.9

-0.4

129.4

248.6

-47.9

in % of revenues

13.9

13.6

-

12.7

24.3

-

Results of operations

43.8

33.8

29.7

102.2

204.2

-50.0

Adjusted net income3)

30.7

30.7

-0.1

81.9

199.7

-59.0

Net Assets as of Reporting Date in EUR m

Total assets

2,582.2

2,745.7

-6.0

2,582.2

2,745.7

-6.0

Equity

870.0

1,028.5

-15.4

870.0

1,028.5

-15.4

Equity ratio in %

33.7

37.5

-

33.7

37.5

-

Net working capital

251.1

281.2

-10.7

251.1

281.2

-10.7

in % of revenues of the last twelve months

18.1

19.9

-

18.1

19.9

-

Capital expenditure

46.9

45.5

3.2

115.3

90.7

27.0

Net financial debt

1,016.6

1,000.4

1.6

1,016.6

1,000.4

1.6

Adjusted EBITDA leverage4)

3.2

2.4

-

3.2

2.4

-

Financial and Liquidity Position

during Reporting Period in EUR m

Cash flow from operating activities

66.7

40.1

66.4

97.3

55.3

75.9

Cash flow from investing activities

-29.0

-61.6

53.0

-92.5

-127.5

27.5

Free cash flow before financing activities

37.7

-21.5

>100.0

4.8

-72.2

>100.0

Employees

Employees as of the reporting date

9,890

9,910

-0.2

9,890

9,910

-0.2

Stock Data

Number of shares at reporting date in million

31.4

31.4

-

31.4

31.4

-

Share price5) at reporting date in EUR

98.85

68.65

44.0

98.85

68.65

44.0

Market capitalization at reporting date in EUR m

3,103.9

2,155.6

44.0

3,103.9

2,155.6

44.0

Share price high5) during reporting period in EUR

100.80

74.00

36.2

100.80

74.00

36.2

Share price low5) during reporting period in EUR

73.65

63.10

16.7

53.00

51.80

2.3

Earnings per share in EUR

0.81

0.59

37.3

1.86

5.22

-64.4

Adjusted earnings per share6) in EUR

0.97

0.96

1.0

2.58

6.31

-59.1

  1. Adjusted EBITDA: Net income before income taxes, net finance expense, amortization/impairment losses of fair value adjustments, depreciation and amortization, impairment losses, restructuring expenses, and one-off income and expenses.
  2. Adjusted EBITA: Net income before income taxes, net finance expense, amortization/impairment losses of fair value adjustments, restructuring expenses, and one-off income and expenses.
  3. Adjusted net income: Net income before amortization/impairment losses of fair value adjustments, restructuring expenses, portfolio adjustments, the balance of one-off income and expenses and related tax effects.
  4. Adjusted EBITDA Leverage: The relation of net financial debt to adjusted EBITDA of the last twelve months according to the credit agreement currently in place.
  5. Xetra closing price.
  6. Adjusted net income per share after non-controlling interests divided by 31.4m shares.
  7. The change has been calculated on a EUR k basis.

.

3

CONTENTS

 4 QUARTERLY STATEMENT AS OF AUGUST 31, 2020 4 Revenue performance

 5 Results of operations 7 Balance sheet

  1. Financial liabilities and credit facilities
  2. Direct Cash Flow
  1. Outlook
  2. TABULARLY FINANCIAL INFORMATION AS OF AUGUST 31, 2020
  1. Consolidated income statement
  2. Consolidated statement of comprehensive income
  3. Consolidated balance sheet
  4. Consolidated statement of changes in equity
  5. Consolidated cash flow statement
  6. Segment data by division
  7. FURTHER INFORMATION
  1. Financial calendar
  1. Imprint

4

QUARTERLY STATEMENT AS OF AUGUST 31, 2020

Gerresheimer AG QUARTERLY STATEMENT DECEMBER 2019 - AUGUST 2020

QUARTERLY STATEMENT AS OF AUGUST 31, 2020

REVENUE PERFORMANCE

Gerresheimer Group revenues were EUR 349.2m in the third quarter of 2020, compared to EUR 358.6m in the prior-year quarter. The main factors negatively impacting revenues were movements in the US dollar and the Brazilian real. On an organic basis-meaning without exchange rate effects and without the Argentine subsidiary deconsolidated as of November 30, 2019-the increase over the period was 0.4%.

Q3

Q3

Change

Q1-Q3

Q1-Q3

Change

in EUR m

2020

2019

in %1)

2020

2019

in %1)

Revenues

Plastics &

Devices

193.8

193.7

0.1

552.4

542.0

1.9

Primary

Packaging

155.8

159.2

-2.1

464.6

463.2

0.3

Glass

Advanced

0.6

6.3

-90.2

2.6

20.1

-87.2

Technologies

Subtotal

350.2

359.2

-2.5

1,019.6

1,025.3

-0.6

Intra-Group

-1.0

-0.6

76.4

-3.6

-1.7

>100.0

revenues

Total revenues

349.2

358.6

-2.6

1,016.0

1,023.6

-0.7

  1. The change has been calculated on a EUR k basis.

Revenues in the Plastics & Devices Division, at EUR 193.8m in the third quarter of 2020, were on the same level as in the prior-year quarter. On an organic basis-meaning without exchange rate effects and without the revenues of the Argentine subsidiary deconsolidated as of

November 30, 2019-revenues in this period went up by 4.3%. All business units contributed to this positive development. Of particular note here was the performance of our syringe business, the Plastic Packaging Business Unit in Europe and the Medical Plastic Systems business.

Revenues in the Primary Packaging Glass Division amounted to EUR 155.8m in the third quarter of 2020, down EUR 3.4m on the prior- year quarter figure of EUR 159.2m. On an organic basis-meaning without exchange rate effects-revenues decreased slightly by 0.5% over the period mentioned. The Moulded Glass Business Unit saw a temporary decline in demand of glass packaging for high-quality cosmetic products as a result of the Covid-19 pandemic. The Tubular Glass Business Unit performed very positively, especially in the North America and Europe regions, and was practically able to make up for part of the revenue shortfall in the cosmetics business.

Revenues in the Advanced Technologies Division came to EUR 0.6m in the third quarter of 2020, compared to EUR 6.3m in the prior-year quarter.

QUARTERLY STATEMENT AS OF AUGUST 31, 2020

5

RESULTS OF OPERATIONS

The Gerresheimer Group generated adjusted EBITDA of EUR 75.0m in the third quarter of 2020, compared to EUR 72.2m in the prior-year quarter. The adjusted EBITDA margin in the third quarter of 2020 was 21.5%, compared to 20.1% in the third quarter of 2019.

In the Plastics & Devices Division, we generated adjusted EBITDA of EUR 52.1m in the third quarter of 2020, compared to EUR 45.7m in the same quarter of the prior year. On an organic basis-meaning without exchange rate effects and without the earnings from the Argentine subsidiary deconsolidated as of November 30, 2019, as well as without the transition effect from financial reporting standard IFRS 16 'Leases', which we were required to apply for the first time from December 1, 2019-the increase over the period was 13.5%. All business units contributed to this positive development. Of particular note here was the performance of our syringe business, the Plastic Packaging Business Unit in Europe and the Medical Plastic Systems business. The transition to IFRS 16 had a positive impact of EUR 1.4m in the Plastics & Devices Division in the third quarter of 2020.

Despite challenges in the cosmetics business, we succeeded in increasing adjusted EBITDA in the Primary Packaging Glass Division by 6.2% or EUR 1.8m, from EUR 30.1m in the prior-year quarter to EUR 31.9m in the third quarter of 2020. On an organic basis-meaning without exchange rate effects and without the IFRS 16 transition effect-the increase over the period was 3.5%. This growth is mainly attributable to the Moulded Glass Business Unit and, in that context, to the very good performance in North America. It should be noted that we recorded insurance reimbursements in the mid-single-digit million euro range for financial losses incurred in the third quarter of 2020 in connection with the furnace damage at our US plant in the financial year 2019 and with a warehouse fire at one of our molded glass plants in Germany in the second quarter of 2020. The compensation for the furnace damage is partly due to the business interruption and would have resulted in higher revenue. The transition to IFRS 16 had a positive impact of EUR 0.6m in the Primary Packaging Glass Division in the third quarter of 2020.

Adjusted EBITDA in our Advanced Technologies Division marked a loss of EUR 2.7m in the third quarter of 2020, compared to a positive EUR 1.8m in the prior-year quarter. In this division, the transition to IFRS 16 had a positive impact of EUR 0.3m.

The head office expenses and consolidation item amounted to EUR 6.3m in the third quarter of 2020, compared to EUR 5.4m in the prior-year quarter. Here, the transition to IFRS 16 had a positive impact of EUR 0.3m.

Q3

Q3

Change

in EUR m

2020

2019

in %1)

Adjusted EBITDA

Plastics & Devices

52.1

45.7

13.9

Primary Packaging Glass

31.9

30.1

6.2

Advanced Technologies

-2.7

1.8

<-100.0

Subtotal

81.3

77.6

4.8

Head office/consolidation

-6.3

-5.4

15.7

Total adjusted EBITDA

75.0

72.2

4.1

  1. The change has been calculated on a EUR k basis.

Margin in %

Q3

Q3

2020

2019

26.9

23.6

20.5

18.9

-

27.9

-

-

-

-

21.5

20.1

Margin in %

Q1-Q3

Q1-Q3

Change

Q1-Q3

Q1-Q3

2020

2019

in %1)

2020

2019

139.5

126.6

10.2

25.3

23.4

99.2

87.6

13.2

21.4

18.9

-10.4

4.0

<-100.0

-

20.0

228.3

218.2

4.6

-

-

-18.1

100.3

<-100.0

-

-

210.2

318.5

-34.0

20.7

31.1

6

QUARTERLY STATEMENT AS OF AUGUST 31, 2020

Gerresheimer AG QUARTERLY STATEMENT DECEMBER 2019 - AUGUST 2020

The following table shows the reconciliation of adjusted EBITDA to net income and to adjusted net income after non-controlling interests:

in EUR m

Q3 2020

Q3 2019

Change

Q1-Q3 2020

Q1-Q3 2019

Change

Adjusted EBITDA

75.0

72.2

2.8

210.2

318.5

-108.3

Depreciation/Amortization

-26.3

-23.3

-3.0

-80.8

-69.9

-10.9

Adjusted EBITA

48.7

48.9

-0.2

129.4

248.6

-119.2

Portfolio optimization

6.1

-0.9

7.0

4.2

-1.8

6.0

One-off income and expenses1)

-3.0

-0.2

-2.8

-6.6

-0.9

-5.7

Total of one-off effects

3.1

-1.1

4.2

-2.4

-2.7

0.3

Amortization of fair value adjustments2)

-8.0

-14.0

6.0

-24.8

-41.7

16.9

Results of operations

43.8

33.8

10.0

102.2

204.2

-102.0

Net finance expense

-5.5

-7.0

1.5

-16.1

-20.3

4.2

Income taxes

-12.7

-7.8

-4.9

-26.7

-18.4

-8.3

Net income

25.6

19.0

6.6

59.4

165.5

-106.1

Total of one-off effects

-3.1

1.1

-4.2

2.4

2.7

-0.3

Amortization of fair value adjustments2)

8.0

14.0

-6.0

24.8

41.7

-16.9

One-off effects in the net finance expense

0.2

-

0.2

0.3

-

0.3

Related tax effect

-

-3.4

3.4

-5.0

-10.2

5.2

Adjusted net income

30.7

30.7

-

81.9

199.7

-117.8

Adjusted net income attributable to non-controlling

interests

0.2

0.6

-0.4

0.8

1.5

-0.7

Adjusted net income after non-controlling interests

30.5

30.1

0.4

81.1

198.2

-117.1

Adjusted earnings per share in EUR after non-controlling

interests

0.97

0.96

0.01

2.58

6.31

-3.73

  1. The one-off income/expenses item consists of one-off items that cannot be taken as an indicator of ongoing business. These include, for example, various reorganization and structure changes that are not reportable as restructuring expenses in accordance with IFRS.
  2. Amortization of fair value adjustments relates to the intangible assets identified at fair value in connection with the acquisitions of Gerresheimer Zaragoza in January 2008; Vedat in March 2011; Neutral Glass in April 2012; Triveni in December 2012; Centor in September 2015; and Sensile Medical in July 2018.

One-off effects had a positive impact of EUR 3.1m in the third quarter of 2020, compared to a negative EUR 1.1m in the prior-year quarter. Portfolio optimization of EUR 6.1m contained in this are mainly in connection with the income from the sale of the land and building in Kuessnacht (Switzerland) and, in the opposite direction, the previously announced reorganization program in the Primary Packaging Glass Division. The negative EUR 3.0m in one-off income and expenses largely relates to the Covid-19pandemic-including to ensuring business continuity, implementing and adhering to safety concepts, and providing incentives to employees-and to the construction of our new plant in Skopje (Republic of North Macedonia).

Net finance expense, at EUR 5.5m in the third quarter of 2020, was EUR 1.5m lower than the EUR 7.0m recorded in the prior-year quarter. Interest income in the amount of EUR 0.4m (Q3 2019: EUR 0.6m) was Offset by interest expenses of EUR 5.4m (Q3 2019: EUR 6.3m). The

decrease in interest expenses is mostly due to drawings on the revolving credit facility being made almost entirely in euros, which incurs a lower expense than US dollar drawings because of the difference in the interest rate. Other financial expenses came to EUR 0.5m, down from EUR 1.3m in the prior-year quarter.

Income taxes in the first nine months of the financial year 2020 resulted in a tax expense of EUR 26.7m, significantly above the EUR 18.4m recorded in the prior-year period. This results in a tax rate of 31.1% for the reporting period, compared to 28.2% in the prior-year period, excluding the EUR 118.5m in non-taxable other operating income due to the derecognition of contingent purchase price components from the Sensile Medical acquisition. The tax rate was higher than the rate in the prior-year period due to the relatively low earnings contribution from subsidiaries domiciled in lower-tax jurisdictions.

QUARTERLY STATEMENT AS OF AUGUST 31, 2020

7

NET ASSETS

FINANCIAL LIABILITIES AND CREDIT FACILITIES

The Gerresheimer Group's total assets decreased by EUR 59.0m, from EUR 2,641.2m as of November 30, 2019 to EUR 2,582.2m as of August 31, 2020. There were no significant changes in balance sheet structure.

Intangible assets, property, plant and equipment and investment property amounted to EUR 2,001.9m as of the reporting date (November 30, 2019: EUR 2,068.3m) and thus decreased by EUR 66.4m. Intangible assets went down relative to November 30, 2019 by EUR 74.6m to EUR 1,282.6m as of August 31, 2020. The decrease mainly relates to exchange rate effects as well as to amortization in the first nine months of the financial year 2020. Our consolidated balance sheet as of August 31, 2020 includes EUR 642.8m in goodwill (November 30, 2019: EUR 672.2m) and EUR 580.1m in customer relationships, brand names, technologies and similar assets (November 30, 2019: EUR 641.3m). Property, plant and equipment amounted to EUR 714.6m as of August 31, 2020, compared to EUR 701.9m as of November 30, 2019. The increase relates to the first-time application of IFRS 16 'Leases' and EUR 94.7m in capital expenditure on property, plant and equipment in the first nine months of the financial year 2020. This was countered by depreciation and impairments in the amount of EUR 76.6m and by exchange rate effects.

The Gerresheimer Group's equity, including non-controlling interests, stood at EUR 870.0m as of August 31, 2020 and was thus significantly lower than the figure as of November 30, 2019 (EUR 941.6m). The decrease is mainly due to effects not recognized through profit or loss from the currency translation of foreign subsidiaries. This made for an equity ratio of 33.7%.

Non-current liabilities were EUR 802.4m as of August 31, 2020, a slight decrease of EUR 6.5m compared to EUR 808.9m at the end of November 2019. This is mainly due to the increase in lease liabilities in connection with the transition to IFRS 16, countered by a reduction in deferred tax liabilities as well as in provisions for pensions and similar obligations. Current liabilities increased by EUR 19.1m, from EUR 890.7m as of November 30, 2019 to EUR 909.8m as of August 31, 2020. This change reflects two opposing factors: On the one hand, current other financial liabilities significantly increased, mainly due to larger drawings on the revolving credit facility while, on the other hand, there was a significant decrease in trade payables.

The Gerresheimer Group's net financial debt developed as follows:

Aug. 31,

Nov. 30,

Aug. 31,

in EUR m

2020

2019

2019

Revolving credit facility

365.5

302.3

368.5

Promissory loans - November

2015

425.0

425.0

425.0

Promissory loans - September

2017

250.0

250.0

250.0

Local borrowings incl. bank

overdrafts

33.6

40.9

31.7

Installment purchase liabilities

1.7

1.7

-

Lease liabilities

35.9

8.6

5.9

Total financial debt

1,111.7

1,028.5

1,081.1

Cash and cash equivalents

95.1

85.8

80.7

Net financial debt

1,016.6

942.7

1,000.4

Net financial debt increased relative to November 30, 2019 by EUR 73.9m to EUR 1,016.6m as of August 31, 2020 (November 30, 2019: EUR 942.7m). The increase is mainly due to larger drawings on the revolving credit facility and higher lease liabilities in connection with the first-time application of IFRS 16. Adjusted EBITDA leverage in accordance with the credit line agreement in force as of August 31, 2020 was 3.2x as of the reporting date (November 30, 2019: 2.4x).

The revolving credit facility (with a facility amount of EUR 550.0m) was drawn by EUR 365.5m as of August 31, 2020 (November 30, 2019: EUR 302.3m), to which are added drawings on ancillary credit facilities in the amount of EUR 6.7m (November30, 2019: EUR 16.5m).

8

QUARTERLY STATEMENT AS OF AUGUST 31, 2020

Gerresheimer AG QUARTERLY STATEMENT DECEMBER 2019 - AUGUST 2020

DIRECT CASH FLOW

OUTLOOK

in EUR m

Adjusted EBITDA

Change in net working capital

Net capital expenditure

Operating cash flow

Net interest paid

Net taxes paid

Pension benefits paid

Other

Free cash flow before acquisitions/divestments

Acquisitions/divestments

Financing activity

Changes in financial resources

Q1-Q3 2020

210.2

-71.0

-91.7

47.5

-7.0

-17.7

-8.1

-9.9

4.8

-

17.2

22.0

Q1-Q3 2019

318.5

-78.6

-88.6

151.3

-8.3

-25.8

-8.3

-137.6

-28.7

-43.5

63.8

-8.4

As a strategic partner to the crisis-resistant pharma and healthcare industry, we continue to anticipate-despite the spread of the coronavirus-revenue growth in the mid-single-digit percentage range for the financial year 2020, as against the comparative figure at constant exchange rates of EUR 1,405.0m for the financial year 2019.1) We expect adjusted EBITDA growth in the low-single-digit percentage range for the financial year 2020, versus a comparative adjusted EBITDA figure of EUR 296.7m2) in the financial year 2019. In addition, we anticipate a positive effect of between EUR 9m and EUR 11m in the financial year 2020 from the transition to IFRS 16 'Leases', which we are required to apply for the first time.

We generated free cash flow before acquisitions/divestments of EUR 4.8m in the first nine months of the financial year 2020, which is EUR 33.5m more than in the comparative prior-year period. During the third quarter of 2020, the sale of the land and building in Kuessnacht (Switzerland) resulted in a EUR 13.1m cash inflow reported in the net capital expenditure item. Compared to the prior-year period, there has been a notable reduction in income taxes paid resulting from the utilization of loss carryforwards before tax consolidation.

In order for the large-scale capex program launched in the financial year 2019 to be continued in the financial year 2020, we expect to incur net capital expenditure of approximately 12% of revenues. Our outlook is based on the assumption that the economic effects of the spread of the coronavirus will last for only a limited period of time and that our plants will be able to produce and ship without restrictions.

  1. Based on the revenues for the financial year 2019 translated at the budgeted exchange rates for 2020 less revenues of EUR 2.8m from Gerresheimer Buenos Aires S.A. (Argentina), which was deconsolidated at the end of the financial year 2019, and in the opposite direction adjusting for the revenues of EUR 17.3m in the Advanced Technologies Division from the canceled project for development of a micro pump for the treatment of diabetes.
  2. Based on adjusted EBITDA for the financial year 2019 under the financial reporting standards applicable in that financial year (in particular, without application of financial reporting standard IFRS 16 'Leases', which is applicable for the first time in financial year 2020), translated at the budgeted exchange rates for 2020. An amount of EUR 0.1m has to be deducted from this for the adjusted EBITDA of Gerresheimer Buenos Aires S.A. (Argentina),

which was deconsolidated at the end of the financial year 2019. It is also necessary to deduct the other operating income from the derecognition of contingent purchase price components from the Sensile Medical acquisition. In contrast, it is necessary to add the other operating expense of EUR 9.2m due to the customer's unexpected cancellation of the project to develop a micro pump for the treatment of diabetes. The cumulative adjustment of revenues recognized in connection with this cancellation in the amount of EUR 17.3m, which had a corresponding negative impact on adjusted EBITDA at constant exchange rates must also be added.

TABULARLY FINANCIAL INFORMATION AS OF AUGUST 31, 2020

9

CONSOLIDATED INCOME STATEMENT

for the period from December 1, 2019 to August 31, 2020

in EUR k

Revenues

Cost of sales

Gross profit

Selling and administrative expenses

Other operating income

Restructuring income

Other operating expenses

Results of operations

Interest income

Interest expense

Other financial expenses

Net finance expense

Net income before income taxes

Income taxes

Net income

Attributable to equity holders of the parent

Attributable to non-controlling interests

Diluted and non-diluted earnings per share (in EUR)

Q3 2020

Q3 2019

Q1-Q3 2020

Q1-Q3 2019

349,171

358,591

1,015,970

1,023,640

-245,751

-260,350

-712,047

-738,218

103,420

98,241

303,923

285,422

-66,588

-66,590

-204,871

-202,762

14,834

4,480

26,889

132,713

9

-

9

102

-7,846

-2,348

-23,800

-11,278

43,829

33,783

102,150

204,197

374

622

1,186

1,841

-5,350

-6,255

-15,246

-18,990

-539

-1,325

-2,001

-3,125

-5,515

-6,958

-16,061

-20,274

38,314

26,825

86,089

183,923

-12,686

-7,778

-26,743

-18,413

25,628

19,047

59,346

165,510

25,397

18,468

58,523

163,967

231

579

823

1,543

0.81

0.59

1.86

5.22

Since December 1, 2019, the new accounting standard IFRS 16 'Leases' has been applied. Prior year figures have not been adjusted.

10

TABULARLY FINANCIAL INFORMATION AS OF AUGUST 31, 2020

Gerresheimer AG QUARTERLY STATEMENT DECEMBER 2019 - AUGUST 2020

CONSOLIDATED STATEMENT OF COMPREHENSIVE INCOME

for the period from December 1, 2019 to August 31, 2020

in EUR k

Q3 2020

Q3 2019

Q1-Q3 2020

Q1-Q3 2019

Net income

25,628

19,047

59,346

165,510

Results from the revaluation of defined benefit plans

-

-

-529

-

Other comprehensive income that will not be reclassified subsequently

-

-

-529

-

to profit or loss

Changes in the fair value of available-for-sale financial assets

-

-

-1

-

Currency translation

-49,796

-715

-91,065

9,645

Other comprehensive income that will be reclassified to profit or loss when specific

conditions are met

-49,796

-715

-91,066

9,645

Other comprehensive income

-49,796

-715

-91,595

9,645

Total comprehensive income

-24,168

18,332

-32,249

175,155

Attributable to equity holders of the parent

-23,966

18,151

-32,197

173,617

Attributable to non-controlling interests

-202

181

-52

1,538

Since December 1, 2019, the new accounting standard IFRS 16 'Leases' has been applied. Prior year figures have not been adjusted.

TABULARLY FINANCIAL INFORMATION AS OF AUGUST 31, 2020

11

CONSOLIDTED BALANCE SHEET

as of August 31, 2020

ASSETS

in EUR k

Aug. 31, 2020

Nov. 30, 2019

Aug. 31, 2019

Non-current assets

Intangible assets

1,282,625

1,357,174

1,483,432

Property, plant and equipment

714,638

701,937

639,246

Investment property

4,602

9,215

4,611

Investments accounted for using the equity method

332

332

297

Income tax receivables

938

878

1,039

Other financial assets

7,725

7,006

6,572

Other receivables

1,979

2,796

3,083

Deferred tax assets

11,142

17,066

17,516

2,023,981

2,096,404

2,155,796

Current assets

Inventories

207,933

185,093

199,501

Trade receivables

195,580

224,170

225,912

Contract assets

10,183

5,392

32,578

Income tax receivables

1,835

5,485

9,056

Other financial assets

18,467

15,448

16,663

Other receivables

29,121

23,416

25,440

Cash and cash equivalents

95,072

85,831

80,725

558,191

544,835

589,875

Total assets

2,582,172

2,641,239

2,745,671

EQUITY AND LIABILITIES

in EUR k

Aug. 31, 2020

Nov. 30, 2019

Aug. 31, 2019

Equity

Subscribed capital

31,400

31,400

31,400

Capital reserve

513,827

513,827

513,827

Other reserve

-137,754

-47,563

-54,962

Retained earnings

447,753

427,439

522,490

Equity attributable to equity holders of the parent

855,226

925,103

1,012,755

Non-controlling interests

14,786

16,454

15,755

870,012

941,557

1,028,510

Non-current liabilities

Deferred tax liabilities

128,465

142,436

163,691

Provisions for pensions and similar obligations

146,976

153,300

136,990

Other provisions

12,110

11,529

10,435

Trade payables

-

35

145

Contract liabilities

2,782

1,471

95

Other financial liabilities

510,334

498,174

679,053

Other liabilities

1,767

1,941

55

802,434

808,886

990,464

Current liabilities

Provisions for pensions and similar obligations

12,659

12,936

14,611

Other provisions

39,548

35,332

37,252

Trade payables

153,141

221,454

163,216

Contract liabilities

6,673

8,717

13,315

Other financial liabilities

607,573

530,560

421,131

Income tax liabilities

9,542

5,851

4,539

Other liabilities

80,590

75,946

72,633

909,726

890,796

726,697

1,712,160

1,699,682

1,717,161

Total equity and liabilities

2,582,172

2,641,239

2,745,671

Since December 1, 2019, the new accounting standard IFRS 16 'Leases' has been applied. Prior year figures have not been adjusted.

12

TABULARLY FINANCIAL INFORMATION AS OF AUGUST 31, 2020

Gerresheimer AG QUARTERLY STATEMENT DECEMBER 2019 - AUGUST 2020

CONSOLIDATED STATEMENT OF CHANGES IN EQUITY

for the period from December 1, 2019 to August 31, 2020

Other comprehensive

income

Currency

Equity

Non-

IFRS 9/

attributable to

Subscribed

Capital

IAS 39

translation

Retained

equity holders of

controlling

Total equity

in EUR k

capital

reserve

reserve

reserve

earnings

the parent

interests

As of November 30/December 1, 2018

31,400

513,827

-6

-67,139

394,578

872,660

17,473

890,133

Conversion effect first-time adoption IFRS 15

-

-

-

-

55

55

-

55

Conversion effect first-time adoption IFRS 9

-

-

2,533

-

-

2,533

-

2,533

Adjusted total as of December 1, 2018

31,400

513,827

2,527

-67,139

394,633

875,248

17,473

892,721

Net income

-

-

-

-

163,967

163,967

1,543

165,510

Other comprehensive income

-

-

-

9,650

-

9,650

-5

9,645

Total comprehensive income

-

-

-

9,650

163,967

173,617

1,538

175,155

Distribution

-

-

-

-

-36,110

-36,110

-3,256

-39,366

As of August 31, 2019

31,400

513,827

2,527

-57,172

522,490

1,012,755

15,755

1,028,510

As of November 30, 2019

31,400

513,827

3,094

-50,657

427,439

925,103

16,454

941,557

Net income

-

-

-

-

58,523

58,523

823

59,346

Other comprehensive income

-

-

-

-90,191

-529

-90,720

-875

-91,595

Total comprehensive income

-

-

-

-90,191

57,994

-32,197

-52

-32,249

Distribution

-

-

-

-

-37,680

-37,680

-1,616

-39,296

As of August 31, 2020

31,400

513,827

3,094

-140,848

447,753

855,226

14,786

870,012

Since December 1, 2019, the new accounting standard IFRS 16 'Leases' has been applied. Prior year figures have not been adjusted.

TABULARLY FINANCIAL INFORMATION AS OF AUGUST 31, 2020

13

CONSOLIDATED CASH FLOW STATEMENT

for the period from December 1, 2019 to August 31, 2020

in EUR k

Q1-Q3 2020

Q1-Q3 2019

Net income

59,346

165,510

Income taxes

26,743

18,413

Amortization/impairment losses of intangible assets

29,222

46,194

Depreciation/impairment losses of property, plant and equipment

76,601

65,405

Share of profit or loss of associated companies and other investment income

-209

-217

Change in other provisions and provisions for employee benefits

-26

-15,447

Gain (-)/Loss (+) on the disposal of non-current assets/liabilities

-8,038

-2,804

Net finance expense

16,061

20,274

Interests paid

-7,528

-8,924

Interests received

574

596

Income taxes paid

-22,362

-27,391

Income taxes received

4,711

1,550

Change in inventories

-30,373

-27,531

Change in trade receivables and other assets

3,269

11,715

Change in trade payables and other liabilities

-49,842

-188,194

Other non-cash expenses/income

-854

-3,823

Cash flow from operating activities

97,295

55,326

Cash received from disposals of non-current assets

13,583

5,132

Cash paid for capital expenditure in intangible assets, property, plant and equipment and financial assets

-106,049

-89,160

Cash paid for the acquisition of subsidiaries, net of cash received

-

-43,499

Cash flow from investing activities

-92,466

-127,527

Distributions to third parties

-39,312

-39,410

Distributions from third parties

209

217

Raising of loans

172,038

346,319

Repayment of loans

-107,769

-240,785

Cash paid for lease and installment purchase

-8,007

-2,532

Cash flow from financing activities

17,159

63,809

Changes in financial resources

21,988

-8,392

Effect of exchange rate changes on financial resources

-5,816

127

Financial resources at the beginning of the period

51,105

61,936

Financial resources at the end of the period

67,277

53,671

Components of the financial resources

Cash and cash equivalents

95,072

80,725

Bank overdrafts

-27,795

-27,054

Financial resources at the end of the period

67,277

53,671

Since December 1, 2019, the new accounting standard IFRS 16 'Leases' has been applied. Prior year figures have not been adjusted.

14

TABULARLY FINANCIAL INFORMATION AS OF AUGUST 31, 2020

Gerresheimer AG QUARTERLY STATEMENT DECEMBER 2019 - AUGUST 2020

SEGMENT DATA BY DIVISION

for the period from December 1, 2019 to August 31, 2020

Primary Packaging

Head office/

Plastics & Devices

Glass

Advanced Technologies

consolidation

Group

Q1-Q3

Q1-Q3

Q1-Q3

Q1-Q3

Q1-Q3

Q1-Q3

Q1-Q3

Q1-Q3

Q1-Q3

Q1-Q3

in EUR k

2020

2019

2020

2019

2020

2019

2020

2019

2020

2019

Segment revenues

552,418

541,981

464,636

463,209

2,578

20,106

-

-

1,019,632

1,025,296

Intra-Group revenues

-3,662

-1,656

-

-

-

-

-

-

-3,662

-1,656

Revenues with third

548,756

540,325

464,636

463,209

2,578

20,106

-

-

1,015,970

1,023,640

parties

Adjusted EBITDA1)

139,495

126,557

99,196

87,629

-10,384

4,029

-18,058

100,252

210,249

318,467

Depreciation and

amortization

-34,924

-31,585

-41,382

-34,803

-1,813

-1,962

-2,705

-1,573

-80,824

-69,923

Adjusted EBITA2)

104,571

94,972

57,814

52,826

-12,197

2,067

-20,763

98,679

129,425

248,544

Net Working Capital

130,837

127,478

116,601

124,185

6,191

31,533

-2,529

-1,976

251,100

281,220

Operating Cash Flow

46,838

36,411

40,767

33,911

-21,335

-11,028

-18,757

98,033

47,513

151,281

Capital expenditure

48,598

48,616

49,073

37,050

16,881

2,151

706

2,956

115,258

90,773

Employees (average)

4,460

4,483

5,177

5,162

108

112

124

115

9,869

9,872

  1. Adjusted EBITDA: Net income before income taxes, net finance expense, amortization/impairment losses of fair value adjustments, depreciation and amortization, impairment losses, restructuring expenses, and one-off income and expenses.
  2. Adjusted EBITA: Net income before income taxes, net finance expense, amortization/impairment losses of fair value adjustments, restructuring expenses, and one-off income and expenses.

FURTHER INFORMATION

15

FINANCIAL CALENDAR

February 18, 2021

Annual Report 2020

April 8, 2021

Publication 1st Quarter 2021

June 9, 2021

Annual General Meeting 2021

July 13, 2021

Interim Report 2nd Quarter 2021

October 12, 2021

Publication 3rd Quarter 2021

IMPRINT

Publisher

Gerresheimer AG

Klaus-Bungert-Strasse 4

40468 Duesseldorf

Germany

Tel

+49

211 61 81-00

Fax

+49

211 61 81-295

E-Mail info@gerresheimer.com

www.gerresheimer.com

Note to the Quarterly Statement

This Quarterly Statement is the English translation of the original German version; in case of deviations between the two, the German version prevails.

Note regarding the rounding of figures

Due to the commercial rounding of figures and percentages, small deviations may occur.

Disclaimer

This Quarterly Statement contains certain future-oriented statements. Future-oriented statements include all statements which do not relate to historical facts and events and contain future-oriented expressions such as "believe", "estimate", "assume", "expect", "forecast", "intend", "could" or "should" or expressions of a similar kind. Such future-oriented statements are subject to risks and uncertainties since they relate to future events and are based on the Company's current assumptions, which may not in the future take place or be fulfilled as expected. The Company points out that such future-oriented statements provide no guarantee for the future and that actual events, including the financial position and profitability of the Gerresheimer Group and developments in the economic and regulatory fundamentals, may vary substantially (particularly on the down side) from those explicitly or implicitly assumed or described in these statements. Even if the actual results for the Gerresheimer Group, including its financial position and profitability as well as the economic and regulatory fundamentals, are in accordance with such future-oriented statements in this Quarterly Statement, no guarantee can be given that this will continue to be the case in the future.

Gerresheimer AG

Klaus-Bungert-Strasse 4

40468 Duesseldorf

Germany

Tel.

+49

211 61 81-00

Fax

+49

211 61 81-295

E-Mail

info@gerresheimer.com

www.gerresheimer.com

Attachments

  • Original document
  • Permalink

Disclaimer

Gerresheimer AG published this content on 13 October 2020 and is solely responsible for the information contained therein. Distributed by Public, unedited and unaltered, on 13 October 2020 07:29:01 UTC